Last update 21 Nov 2024
GB-251
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms + [1] |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Login to view timeline
Structure
Molecular FormulaC39H67N5O7 |
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N |
CAS Registry474645-27-7 |
View All Structures (2)
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with GB-251注射用GB251在HER-2阳性转移性乳腺癌患者中开放、剂量递增、单次给药的耐受性，安全性，药代动力学及免疫原性特征的Ia期临床研究
[Translation] Phase Ia clinical study of the tolerability, safety, pharmacokinetics and immunogenicity of GB251 for injection in patients with HER-2 positive metastatic breast cancer with open-label, dose-escalation and single-dose administration
100 Clinical Results associated with GB-251
Login to view more data
100 Translational Medicine associated with GB-251
Login to view more data
100 Patents (Medical) associated with GB-251
Login to view more data
100 Deals associated with GB-251
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HER2 Positive Breast Cancer | Phase 1 | CN | 13 Apr 2021 | |
| Breast Cancer | Discovery | CN | - | |
| Stomach Cancer | Discovery | CN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free